Gilman Hill Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Gilman Hill Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-650	Closed	-$290K	–	246
2026 Q1	$290K	Buy	+650	New	+$303K	0.04%	188
2022 Q1	–	Sell	-1,025	Closed	-$225K	–	224
2021 Q4	$225K	Buy	+1,025	New	+$199K	0.05%	200
2020 Q3	–	Sell	-700	Closed	-$203K	–	166
2020 Q2	$203K	Buy	+700	New	+$190K	0.08%	152

Other funds holding VRTX

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Barlow Wealth Partners Louisville, Kentucky $926M AUM 20.71% 1-Year Est. Return